Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles

Clinical trial NCT02063269 · UNKNOWN

Trial details

NCT number: NCT02063269
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2014-02-01
Primary completion: 2017-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.